AS

Arti Sharma

Active Director Additional Director DIN 09826405
DIN 09826405 First appointment Dec 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value •••• Premium profile

About Arti Sharma

Data last updated:

Arti Sharma is an Additional Director at Routes Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Routes Pharmaceuticals Private Limited reported revenue of ₹28.9 Lakh (FY 2025).

DIN 09826405
Primary Designation Additional Director
Industry Chemicals
First Appointment 01 Dec 2022
Oldest Company Age 7 yrs
Largest company Routes Pharmaceuticals Private Limited · ₹28.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director01 Dec 20222019₹28.9 Lakh (FY 2025)Active

Board colleagues of Arti Sharma

NameDINCompanyDesignation
Sudeepta Sinha08448540Routes Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Routes Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arti Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arti Sharma

Arti Sharma currently holds 1 directorship: Routes Pharmaceuticals Private Limited (Additional Director, since 01 Dec 2022, revenue ₹28.9 Lakh (FY 2025)).

Arti Sharma was first appointed on 01 Dec 2022 as Additional Director at Routes Pharmaceuticals Private Limited.

The current boards of Arti Sharma's companies include Sudeepta Sinha (Routes Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available